TRIM21 and glioma: Experiments in xenograft murine models confirmed the oncogenic potential of TRIM21 since mice injected with glioma cells overexpressing TRIM21 or depleted of TRIM21, exhibited decreased and increased OS, respectively, compared to control mice.